Pulse dose rate brachytherapy: Optimization and place of imaging;La curiethérapie de débit pulsé: Optimisation et place de l'imagerie

Cancer/Radiotherapie

Volumn 7, Issue 2, 2003, Pages 136-146

  Poupon, L ^a   Castelain, B ^a   Lartigau, E ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

Brachytherapy; Imaging; Optimisation; Pulse dose rate; Remote afterloading

Indexed keywords

ALGORITHM; BRACHYTHERAPY; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RADIATION PROTECTION; REVIEW; TREATMENT PLANNING;

EID: 0038416070     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(03)00017-9     Document Type: Review

References (56)

1. AAPM. Report 41: Remote afterloading technology. AAPM; 1993.
2. AAPM. Comprehensive QA for radiation oncology: Report of AAPM Radiation Therapy Committee Task Group 40. AAPM; 1994. p. 581-618.
3. Anderson LL. A natural volume-dose histogram for brachytherapy. Med Phys 1986;13:898-903.
4. Barillot I, Horiot JC, Maingon P, Bone-Lepinoy M, Vaillant D, Feutray S. Maximum and mean bladder dose defined from ultrasonography, Comparison with the ICRU reference in gynaecological brachytherapy. Radiother Oncol 1994;30:231-8.
5. Brenner DJ, Hall EJ. Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1991;20(1):181-90.
6. Bridier A, Kafrouni H, Houlard JP, Dutreix A, editors. Colloque international sur la dosimétrie en curiethérapie. Comparaison des distributions de dose en curiethérapie interstitielle autour de sources continues et discontinues, ed, IAEA, IAEA-SM-298/23. Autriche: IAEA: Vienne; 1987.
7. Dutreix A. Rôle du débit de dose en curiethérapie. Manuel Pratique de Curiethérapie. Paris: Hermann, Editor; 1992. p. 71-84.
8. Dutreix A, Wambersie A. Étude de la répartition des doses autour de sources ponctuelles alignées. Radiol 1968;7:389-400.
9. Fellner C, Potter R, Knocke TH, Wambersie A. Comparison of radiography-and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 2001;58(1):53-62.
10. Fellner C, Pötter R, Knocke TH, Wambersie A. Comparison of radiography-and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 2001;58:53-62.
11. Fowler J, Mount M. Pulsed brachytherapy: the conditions for no significant loss of therapeutic ratio compared with traditional low dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1992;23(3):661-9.
12. Fowler JF, Van Limbergen EF. Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues. Int J Radiat Oncol Biol Phys 1997;37(4):877-83.
13. Gerbaulet A, Haie-Meder C, Lambin P, Karmar A, Delapierre M, Scalliet P, et al. Étude randomisée comparant deux débits de dose en curiethérapie préopératoire des cancers utérins (311 cas. Bull Cancer Radiother 1991;78:484-5.
14. Hall EJ. Dose rate considerations. In: Mould RF, et al., editors. Brachytherapy from Radium to Optimization. Nucletron International B.V; 1994. p. 9-18.
15. Hennequin C, Mazeron JJ, Chotin G. How to use the Paris system in the year 2001? Radiother Oncol 2001;58(1):5-6.
16. Henschke UK. Afterloading applicator for radiation therapy of carcinoma of the uterus. Radiology 1960;74:834.
17. Hunter R, Wong F, Moore C, Notley H, Wilkinson J. Bladder base dosage in patients undergoing intracavitary therapy. Radiother Oncol 1986;7:189-97.
18. ICRU, Report 38: Dose and volume specification for reporting intracavitary therapy in gynecology. USA: ICRU: Bethesda, MD; 1985.
19. ICRU, Report 50: Prescribing, recording and reporting photon beam therapy. USA: ICRU: Bethesda, MD; 1993.
20. ICRU, Report 58: Dose and volume specification for reporting interstitial therapy. USA: ICRU: Bethesda, ; 1997.
21. ICRU, Report 62: Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50). USA: ICRU: Bethesda; 1999.
22. Kouwenhoven E, Kuipers F, Kwa S, Van der Laarse R. Interactive Inverse Optimization in PLATO Brachytherapy Remote Afterloading, 14.2. Nucletron R&D; 2001. p. 5 (personal communication).
23. Lessard E, Pouliot J. Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function. Med Phys 2001;28(5):773-9.
24. Levendag PC, Schmitz PI, Jansen PP, Senan S, Eijkenboom WM, Sipkema D, et al. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 1997;38(3):497-506.
25. Marinello G. Review of the recommendations and specification of LDR/HDR brachytherapy carcinoma in cervix (personal communication). in GEC-ESTRO Workshop, 1993 Venezia (Italy).
26. Marinello G, Pierquin B, Grimard L, Barret C. Dosimetry of intraluminal brachytherapy. Radiother Oncol 1992;23:213-6.
27. Mazeron JJ, Boisserie G, Baillet F. Pulse dose rate curietherapy]. Bull Cancer Radiother 1995;82(3):332-5.
28. Mazeron JJ, Simon JM, Crook JM, Calitchi E, Otmezguine Y, Le Bourgeois JP, et al. Influence of dose rate on local control of breast carcinomas treated by external beam irradiation plus iridium 192 implant. Int J Radiat Oncol Biol Phys 1992;21:1173-7.
29. Mazeron JJ, Simon JM, Le Pechoux C, Crook JM, Grimard L, Piedbois P, et al. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium 192. Radiother Oncol 1991;21:39-47.
30. Meertens H, Borger J, Steggerda M, Blom A. Evaluation and optimisation on interstitial brachytherapy dose distributions. In: Mould RF, et al., editors. in Brachytherapy from radium to optimization. Nucletron International B.V; 1994. p. 300-6.
31. Meigooni AS, Kleinman MT, Johnson JL, Mazloomdoost D, Ibbott S. Dosimetric characteristics of a new high-intensity iridium 192 source for remote afterloading. Med Phys 1997;24(12):2008-13.
32. Mishra V, Waterman FM, Suntharalingam N. Anisotropy of an 192Ir high dose rate source measured with a miniature ionization chamber. Med Phys 1997;24(5):751-5.
33. Mizoe J. Analysis of the dose-volum histogram in uterine cervical cancer by diagnostic CT. Strahlenther Onkol 1990;4:279-84.
34. Munzenrider JE, Pilepich M, Rene-Ferrero JB, Tchakarova I, Carter BL. Use of body scanner in radiotherapy treatment planning. Cancer 1977;40(1):170-9.
35. Niroomand-Rad A, Thomadsen B, Vainio P. Evaluation of the reconstruction of brachytherapy implants in three-dimensions from stereo radiographs. Radiother Oncol 1987;8:337-42.
36. Paul JM, Philip PC, Brandenburg RW, Koch RF. Comparison between continuous and discrete sources in the Paris system of implants. Med Phys 1989;16:414-24.
37. Peiffert D, Castelain B, Thomas L, Ardiet JM, Baillet F, Mazeron JJ. Pulsed dose rate brachytherapy in head and neck cancers, Feasibility studyof a French cooperative group. Radiother Oncol 2001;58(1):71-5.
38. Pötter R, Van Limbergen E, Gerstner N, Wambersie A. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol 2001;58:11-8.
39. Poupon L, Bauvois C, Ala Eddine C, Coche-Dequeant B, Lartigau E. Dosimetry optimisation and MRI tumour volume definition in head and neck LDR brachytherapy. Radiother Oncol 2001;60((suppl. 1) S5):13.
40. Pourquier H, Delard R, Achille E. A quantified approach of the analysis and prevention of urinary complications in radiotherapeutic treatment of cancer of the cervix. Int J Radiat Oncol Biol Phys 1987;13:1025-33.
41. Rosenwald JC. Calcul des distributions de dose. in Manuel pratique de Curiethérapie. Hermann: Editor; 1992. p. 29-45.
42. Rosenwald JC, Dutreix A. Étude d'un programme sur ordinateur pour le calcul des doses en curiethérapie gynécologique. J Radiol Electrol Med Nucl 1970;51:651.
43. Sauer OA, Götz-Gersitz U, Güllenstern M, Baier K, Herbolsheimer M. Precision of the dose calculated for bladder and rectum in high dose rate gynaecological brachytherapy. Endocuriether Hyperther Oncol 1994;10:79-82.
44. Saw CB, Suntharalingam N. Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys 1991;20:135-9.
45. Schoeppel S, La Vigne M, Martel M, Mc Shan D, Fraass B, Roberts L. Three-dimensional treatment planning of intracavity gynecologic implants: analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys 1993;28:277-83.
46. Serkies K, Badzio A, Jereczek-Fossa B, Tarnawska Z, Nowak R, Szewczyk P, et al. Rectal doses in intracavitary brachytherapy of gynecological malignancies: comparison of two dosimetric methods. Radiother Oncol 2001;58:37-41.
47. SFPH. Rapport 11: Contrôle de qualité en curiethérapie à haut débit de dose. SFPH; 1995.
48. Thomas L. Contribution of imaging in radiotherapy planning in uterine cervix cancers]. Cancer Radiother 2000;4(2):127-32.
49. Thomas L, Barillot I. Radiotherapy for tumors of the uterine cervix, Gross tumor volume and clinical target volume]. Cancer Radiother 2001;5(5):629-42.
50. Van den Bergh F, Meertens H, Moonen L, Van Bunningen B. Bom A., The use of transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. Radiother Oncol 1998;47:85-90.
51. Van der Laarse R. The stepping source dosimetry system as an extension of the Paris system. In: Mould RF, et al., editors. in Brachytherapy from radium to optimization. Nucletron International B.V; 1994. p. 319-30.
52. Van der Laarse R, Prins TPE. Introduction to HDR Brachytherapy Optimisation. In: Mould RF, et al., editors. Brachytherapy from Radium to Optimization. Nucletron International B.V; 1994. p.331-51.
53. van Eijkeren M, Thienpont M, Boterberg T, De Neve W. Implementation, uptime, and safety of a pulsed dose rate afterloading machine. Int J Radiat Oncol Biol Phys 1996;36(5):1233-7.
54. Visser AG, Symonds RP. Dose and volume specification for reporting gynaecological brachytherapy: time for a change. Radiother Oncol 2001;58:1-4.
55. Williamson JF, Li Z. Monte Carlo aided dosimetry of the microselectron pulsed and high dose-rate 192Ir sources. Med Phys 1995;22(6):809-19.
56. Wu A, Ulin K, Sternik ES. A dose homogeneity index for evaluating 192 Ir breast implants. Med Phys 1988;15(1):104-7.